Statistics for 89bio (id:6464 ETNB)

Valuation metrics

Market cap

932.43M

Enterprise value

455.38M

Trailing P/E (ttm)

-4.38

Forward P/E

-2.76

PEG ratio

-2.76

Price/Sales (ttm)

Price/Book (mrq)

2.23

Enterprise Value/Revenue

Enterprise Value/EBITDA

-1.50

Overview

Shares outstanding

117.58M

Float

68.17M

Shares short

5.38M

% Held by insiders

0.01%

% Held by institutions

0.94%

Average volume (10 days)

1.25M

Average volume (90 days)

Price summary

52-Week low

7.00

52-Week high

16.63

52-Week change

9.59%

Beta

0.98

50-Day moving average

8.19

200-Day moving average

9.09

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-41.36%

Return on equity

-73.31%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-303,812,000.00

Net income to common (ttm)

-288,960,000.00

Diluted EPS (ttm)

-2.96

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

423.77M

Total cash per share (mrq)

3.99

Total debt (mrq)

37.57M

Total Debt/Equity (mrq)

9.94

Current ratio (mrq)

1.17K%

Book value per share (mrq)

3.56

Cash flow

Cash flow statement

-280,536,000.00

Levered free cash flow (LFCF)

-180,680,752.00